Owens & Minor (OMI) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
NEW YORK, NY / ACCESSWIRE / July 23, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Owens & Minor, Inc. ("OMI" or the "Company") (NYSE:OMI). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
Owens & Minor, Inc. (NYSE:OMI ) Special Conference Call July 23, 2024 8:30 AM ET Company Participants Jacqueline Marcus - Investor Relations, Alpha IR Group Edward Pesicka - President and Chief Executive Office Jonathan A. Leon - Interim CFO and SVP of Finance and Corporate Treasurer Conference Call Participants Stephanie Davis - Barclays John Stansel - JP Morgan Daniel Clark - Leerink Partners Allen Lutz - Bank of America Operator Greetings, welcome to Owens & Minor Special Conference Call to discuss its proposed acquisition of Rotech Healthcare Holdings, Inc. At this time, all participants are in a listen-only mode.
NEW YORK, NY / ACCESSWIRE / July 23, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Owens & Minor, Inc. ("Owens & Minor") (NYSE:OMI) concerning possible violations of federal securities laws. On May 3, 2024, Owens announced 1Q24 financial results that beat consensus estimates.
Medical supplies distributor Owens & Minor said on Tuesday it has agreed to buy medical equipment firm Rotech Healthcare for $1.36 billion in cash to expand its presence in home-based care.
NEW YORK, NY / ACCESSWIRE / July 20, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Owens & Minor, Inc. ("Owens & Minor") (NYSE:OMI) concerning possible violations of federal securities laws. On May 3, 2024, Owens announced 1Q24 financial results that beat consensus estimates.
NEW YORK, NY / ACCESSWIRE / July 19, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Owens & Minor, Inc. ("Owens & Minor") (NYSE:OMI) concerning possible violations of federal securities laws. On May 3, 2024, Owens announced 1Q24 financial results that beat consensus estimates.
NEW YORK, NY / ACCESSWIRE / July 18, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Owens & Minor, Inc. ("Owens & Minor") (NYSE:OMI) concerning possible violations of federal securities laws. On May 3, 2024, Owens announced 1Q24 financial results that beat consensus estimates.
NEW YORK, NY / ACCESSWIRE / July 17, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Owens & Minor, Inc. ("Owens & Minor") (NYSE:OMI) concerning possible violations of federal securities laws. On May 3, 2024, Owens announced 1Q24 financial results that beat consensus estimates.
NEW YORK, NY / ACCESSWIRE / July 16, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Owens & Minor, Inc. ("Owens & Minor") (NYSE:OMI) concerning possible violations of federal securities laws. On May 3, 2024, Owens announced 1Q24 financial results that beat consensus estimates.
NEW YORK, NY / ACCESSWIRE / July 14, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Owens & Minor, Inc. ("Owens & Minor") (NYSE:OMI) concerning possible violations of federal securities laws. On May 3, 2024, Owens announced 1Q24 financial results that beat consensus estimates.
NEW YORK, NY / ACCESSWIRE / July 14, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Owens & Minor, Inc. ("OMI" or the "Company") (NYSE:OMI). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.